Forte Biosciences (FBRX) Return on Sales (2017 - 2019)
Forte Biosciences (FBRX) posted quarterly Return on Sales of 11.76% for Q4 2019, up 792.0% year-over-year from 1.32% in Q4 2018, and up 43.51% quarter-over-quarter from 20.82% in Q3 2019.
Forte Biosciences (FBRX) Return on Sales (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has reported Return on Sales for 3 consecutive years, with 11.76% the latest figure, recorded in Q4 2019.
- In Q4 2019, Return on Sales rose 792.0% year-over-year to 11.76%; the TTM figure through Dec 2019 stood at 13.15% (down 1312.0% YoY), while the FY2019 annual figure was 17.64%, down 1762.0% from the prior year.
- Return on Sales improved to 11.76% in Q4 2019 per FBRX's latest filing, from 20.82% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q3 2018 and bottomed at 20.82% in Q3 2019.
- Historically, Return on Sales has averaged 12.52% across 3 years, with a median of 12.51% in 2017.
- On a YoY basis, Return on Sales climbed as much as 1685 bps in 2019 and fell as far as 2082 bps in 2019.
- Forte Biosciences' Return on Sales stood at 10.84% in 2017, then plunged by 82 bps to 19.68% in 2018, then surged by 40 bps to 11.76% in 2019.
- Business Quant data shows FBRX's Return on Sales at 11.76% in Q4 2019, 20.82% in Q3 2019, and 1.03% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Forte Biosciences | 1.63 Bn | 1.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -11.76% |
| Sep 30, 2019 | -20.82% |
| Jun 30, 2019 | -1.03% |
| Mar 31, 2019 | -18.98% |
| Dec 31, 2018 | -19.68% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | -17.88% |
| Mar 31, 2018 | -14.31% |
| Dec 31, 2017 | -10.84% |
| Sep 30, 2017 | -9.95% |
| Jun 30, 2017 | -12.51% |